UPCOMING SESSIONS in ET
Fri, Nov 20, 2026
6:00 – 7:00 AM Bangkok
Sadness, Anger and Fear: Coping With the Emotions of Illness Hamide Eygoren Register
UPCOMING SESSIONS in ET
Fri, Nov 20, 2026 · 6:00 – 7:00 AM Bangkok
Sadness, Anger and Fear: Coping With the Emotions of Illness
Hamide Eygoren
Register
View all sessions

Earlier diagnosis, new therapies boost ATTR-CM survival rates: Review

Source
Sickle Cell Anemia News

More recent clinical trials also show less advanced disease in patients

People with transthyretin amyloid cardiomyopathy (ATTR-CM) enrolled in more recent clinical trials show less advanced disease and improved survival compared with those in earlier studies, likely reflecting early diagnosis and advances in treatment.

That’s according to a systematic review of 58 published studies covering 13 ATTR-CM clinical trials conducted between 2008 and 2022.